首页> 外文期刊>Journal of Medicinal Chemistry >Synthesis and biological evaluation of aryl-phospho-indole as novel HIV-1 non-nucleoside reverse transcriptase inhibitors
【24h】

Synthesis and biological evaluation of aryl-phospho-indole as novel HIV-1 non-nucleoside reverse transcriptase inhibitors

机译:新型HIV-1非核苷逆转录酶抑制剂芳基-磷酸吲哚的合成及生物学评价

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

A novel series of 3-aryl-phospho-indole (API) non-nucleoside reverse transcriptase inhibitors of HIV-1 was developed. Chemical variation in the phosphorus linker led to the discovery of 3-phenyl-methyl-phosphinate-2- carboxamide 14, which possessed excellent potency against wild-type HIV-1 as well as viruses bearing K103N and Y181C single mutants in the reverse transcriptase gene. Chiral separation of the enantiomers showed that only R enantiomer retained the activity. The pharmacokinetic, solubility, and metabolic properties of 14 were assessed.
机译:开发了一系列新的HIV-1的3-芳基-磷酸吲哚(API)非核苷逆转录酶抑制剂。磷接头中的化学变化导致发现了3-苯基-甲基次膦酸酯-2-羧酰胺14,它对野生型HIV-1以及在逆转录酶基因中带有K103N和Y181C单突变体的病毒具有极好的效力。对映异构体的手性分离显示仅R对映异构体保留了活性。评估了14种的药代动力学,溶解度和代谢特性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号